IP Library › Assignment 061615/0332
Patent Assignment
Reel/Frame 061615/0332

Assignment of Assignor's Interest

Recorded: 2022-11-01 Pages: 7
Assignor
Assignee
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BINGER STRASSE 173, INGELHEIM AM RHEIN, 55216, GERMANY
Covered Properties (21)
Methods and Compositions for Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen in Cancer
Combination Cancer Therapy with Anti-Cancer Agents and Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen
Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen and Their Methods of Use
Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen and Their Methods of Use
Methods and Compositions for Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen in Cancer
Application: 16/103,764 →
Publication: US 2019/0071502
Antibodies and Methods of Use Thereof
Application: 16/877,335 →
Publication: US 2020/0291127
Antibodies and Methods of Use Thereof
Application: 16/877,346 →
Publication: US 2020/0291128
Antibodies and Methods of Use Thereof
Application: 16/877,352 →
Publication: US 2020/0325244
Antibodies and Methods of Use Thereof
Application: 16/877,368 →
Publication: US 2020/0291116
Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen and Their Methods of Use
Application: 16/926,306 →
Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen and Their Methods of Use
Application: 16/926,355 →
Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen and Their Methods of Use
Application: 17/199,205 →
Publication: US 2021/0371532
Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen and Their Methods of Use
Application: 17/199,258 →
Publication: US 2022/0033504
Antibodies and Methods of Use Thereof
Application: 17/247,767 →
Publication: US 2021/0147572
Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen and Their Methods of Use
Application: 17/663,393 →
Publication: US 2022/0332831
Generating High Affinity Antibodies to Target Non-Classical Mhc I Hla-E Molecules and Classical Hla I Molecules Presenting Neo-Peptides Identified from Alternative Antigen Processing Routes
Application: 62/449,954 →
Generating High Affinity Antibodies to Target Non-Classical Mhc I Hla-E Molecules and Classical Hla I Molecules Presenting Neo-Peptides Identified from Alternative Antigen Processing Routes
Application: 62/460,585 →
Combination Cancer Therapy with Anti-Cancer Agents and Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen
Application: 62/634,522 →
Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen and Their Methods of Use
Application: 62/702,143 →
Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen and Their Methods of Use
Application: 63/032,747 →
Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen and Their Methods of Use
Application: 63/032,886 →
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 23, 2018
From: WEIDANZ, JON
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 044706/0207 →
Assignment of Assignor's Interest Jan 23, 2018
From: WEIDANZ, JON
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 044700/0351 →
Assignment of Assignor's Interest Aug 23, 2018
From: WEIDANZ, JON
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 046683/0927 →
Assignment of Assignor's Interest Feb 24, 2019
From: WEIDANZ, JON
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 048418/0779 →
Assignment of Assignor's Interest Jun 13, 2019
From: WEIDANZ, JON
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 049459/0299 →
Assignment of Assignor's Interest Jul 19, 2019
From: WEIDANZ, JON
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 049801/0739 →
Security Interest Nov 15, 2019
From: ABEXXA BIOLOGICS, INC.
To: BOEHRINGER INGELHEIM VENTURE FUND USA, INC.
Reel/Frame 051016/0081 →
Assignment of Assignor's Interest Jul 12, 2020
From: WEIDANZ, JON; UPCHURCH-ANGE, KATHERINE
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 053186/0897 →
Assignment of Assignor's Interest Jul 12, 2020
From: WEIDANZ, JON; UPCHURCH-ANGE, KATHERINE
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 053186/0733 →
Assignment of Assignor's Interest Jul 28, 2020
From: WEIDANZ, JON; UPCHURCH-ANGE, KATHERINE
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 053335/0652 →
Assignment of Assignor's Interest Jul 28, 2020
From: WEIDANZ, JON; UPCHURCH-ANGE, KATHERINE
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 053335/0664 →
Assignment of Assignor's Interest Sep 22, 2020
From: WEIDANZ, JON
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 053846/0249 →
Assignment of Assignor's Interest Mar 17, 2021
From: WEIDANZ, JON; UPCHURCH-ANGE, KATHERINE
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 055622/0879 →
Assignment of Assignor's Interest Mar 17, 2021
From: WEIDANZ, JON; UPCHURCH-ANGE, KATHERINE
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 056069/0180 →
Assignment of Assignor's Interest Apr 5, 2021
From: WEIDANZ, JON
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 055822/0655 →
Assignment of Assignor's Interest Apr 6, 2021
From: WEIDANZ, JON
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 055843/0090 →
Assignment of Assignor's Interest Sep 30, 2021
From: WEIDANZ, JON; UPCHURCH-ANGE, KATHERINE
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 057673/0912 →
Merger Jan 6, 2022
From: ABEXXA BIOLOGICS, INC.
To: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Reel/Frame 058584/0680 →
Merger May 13, 2022
From: ABEXXA BIOLOGICS, INC.
To: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Reel/Frame 059906/0624 →
Assignment of Assignor's Interest May 13, 2022
From: WEIDANZ, JON; UPCHURCH-ANGE, KATHERINE
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 060068/0737 →